CLINICAL_TRIALS
trial_result
· 2016-09-16
Clinical Trial Update: Pazopanib In Stage IIIB/IV NSCLC Lung Cancer After Progression on First Line Therapy Containing Bevacizumab [Phase 2]
Summary
A Phase 2 trial evaluating pazopanib in patients with stage IIIB/IV non-small cell lung cancer after progression on first-line therapy containing bevacizumab ha…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: UNC Lineberger Comprehensive Cancer Center | Conditions: Lung Cancer | Phase 2 | Status: COMPLETED | Results posted: 2016-09-16